• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: PENUMBRA, INC. ARTEMIS NEURO EVACUATION DEVICE; GWG

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

PENUMBRA, INC. ARTEMIS NEURO EVACUATION DEVICE; GWG Back to Search Results
Model Number AP28-A
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Hematoma (1884)
Event Date 05/18/2021
Event Type  Injury  
Manufacturer Narrative
The product was not returned for evaluation.Potential adverse events in the labeling with the artemis neuro evacuation device include, but are not limited to, hematoma expansion, intraventricular hemorrhage, hydrocephalous, including death.From the information provided, there is no indication that there was any device malfunction, nonconformance, or misuse that contributed to the reported event.The manufacturing records for this lot were reviewed and did not reveal any outstanding discrepancies, design, or quality concerns.
 
Event Description
On (b)(6) 2021, the patient underwent a microneurosurgery procedure to treat an intracerebral hemorrhage (ich) using artemis neuro evacuation device (artemis).On (b)(6) 2021, the computed tomography (ct) scan revealed an interval increase in size of right basal ganglia hematoma and increased associated mass effect compared to the (b)(6) 2021 exam, with suspected interval rebleeding.It should be noted that a follow-up ct scan was done on (b)(6) 2021 and the interval rebleeding was resolved.Increase in size of right basal ganglia hematoma was reported to be an adverse event with a possible relationship to the artemis and index procedure.
 
Event Description
On (b)(6) 2021, the patient underwent a microneurosurgery procedure to treat an intracerebral hemorrhage (ich) using artemis neuro evacuation device (artemis).On 18-may-2021, the computed tomography (ct) scan revealed an interval increase in size of right basal ganglia hematoma and increased associated mass effect compared to the (b)(6) 2021 exam, with suspected interval rebleeding.It should be noted that a follow-up ct scan was done on (b)(6) 2021 and the interval rebleeding was resolved.Increase in size of right basal ganglia hematoma was adjudicated to be an adverse event related to the artemis, the index procedure, the index intracerebral hemorrhage (ich) and to the comorbidity by the clinical events committee (cec).On 02-nov-2021, we received an update indicating that the clinical events committee (cec) determined the intracranial hemorrhage to be an adverse event related to the artemis, the index procedure and the index intracerebral hemorrhage (ich).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARTEMIS NEURO EVACUATION DEVICE
Type of Device
GWG
Manufacturer (Section D)
PENUMBRA, INC.
one penumbra place
alameda CA 94502
Manufacturer Contact
veronica farris
one penumbra place
alameda, CA 94502
5107483200
MDR Report Key12110517
MDR Text Key260083108
Report Number3005168196-2021-01464
Device Sequence Number1
Product Code GWG
UDI-Device Identifier00814548017877
UDI-Public00814548017877
Combination Product (y/n)Y
Reporter Country CodeUS
PMA/PMN Number
K171332
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Study,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 01/01/2005,12/08/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/02/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date03/07/2022
Device Model NumberAP28-A
Device Catalogue NumberAP28
Device Lot NumberC24776
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? Yes
Date Report Sent to FDA01/01/2005
Date Report to Manufacturer01/10/2005
Date Manufacturer Received11/02/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured03/08/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age44 YR
Patient SexFemale
-
-